Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimated cognitive decline in patients with schizophrenia: A multicenter study.
Fujino H, Sumiyoshi C, Yasuda Y, Yamamori H, Fujimoto M, Fukunaga M, Miura K, Takebayashi Y, Okada N, Isomura S, Kawano N, Toyomaki A, Kuga H, Isobe M, Oya K, Okahisa Y, Takaki M, Hashimoto N, Kato M, Onitsuka T, Ueno T, Ohnuma T, Kasai K, Ozaki N, Sumiyoshi T, Imura O, Hashimoto R; for COCORO. Fujino H, et al. Among authors: oya k. Psychiatry Clin Neurosci. 2017 May;71(5):294-300. doi: 10.1111/pcn.12474. Epub 2016 Dec 15. Psychiatry Clin Neurosci. 2017. PMID: 27804186 Free article.
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms.
Takeuchi H, Takekita Y, Hori H, Oya K, Miura I, Hashimoto N, Yasui-Furukori N. Takeuchi H, et al. Among authors: oya k. Hum Psychopharmacol. 2021 Nov;36(6):e2804. doi: 10.1002/hup.2804. Epub 2021 Jul 9. Hum Psychopharmacol. 2021. PMID: 34241916 Free PMC article.
Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.
Oya K, Sakuma K, Esumi S, Hashimoto Y, Hatano M, Matsuda Y, Matsui Y, Miyake N, Nomura I, Okuya M, Iwata N, Kato M, Hashimoto R, Mishima K, Watanabe N, Kishi T. Oya K, et al. Neuropsychopharmacol Rep. 2019 Sep;39(3):241-246. doi: 10.1002/npr2.12056. Epub 2019 Apr 26. Neuropsychopharmacol Rep. 2019. PMID: 31026388 Free PMC article.
178 results